Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company is headquartered in Englewood, Colorado and currently employs 6 full-time employees. The company went IPO on 2011-05-19. The firm is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.
Le segment de revenus le plus important est Ampio Pharmaceuticals Inc, avec un chiffre d'affaires de Construction Design-build lors du dernier rapport de résultats. En termes géographiques, United States and Canada est le marché principal pour Ampio Pharmaceuticals Inc, avec un chiffre d'affaires de 71,542,773.